Alterity Therapeutics Ltd
ASX:ATH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Alterity Therapeutics Ltd
ASX:ATH
|
AU |
|
Excel Cell Electronic Co Ltd
TWSE:2483
|
TW |
|
Multitude SE
F:FRU
|
FI |
|
C
|
Cartica Acquisition Corp
NASDAQ:CITE
|
US |
|
C
|
Compass Digital Acquisition Corp
NASDAQ:CDAQ
|
KY |
Shareholder Yield
Current shareholder yield for ATH is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
ATH Price
Alterity Therapeutics Ltd
| Average Annual Return | -22.71% |
| Standard Deviation of Annual Returns | 35.15% |
| Max Drawdown | -91% |
| Market Capitalization | 110.9m AUD |
| Shares Outstanding | 217 510 000 |
| Percentage of Shares Shorted |
N/A
|
ATH Return Decomposition
Main factors of price return
Stock Splits
ATH's latest stock split occurred on Jun 3, 2026
The company executed a 1-for-50 stock split, meaning that for every 50 shares held, investors received 1 new share.
Before the split, ATH traded at 0.009 per share. Afterward, the share price was about 0.395.
The adjusted shares began trading on Jun 3, 2026. This was the only stock split in ATH's history.
